Market Access News | pharmaphorum

News

Trump orders stockpiling of essential medicine ingredients

Trump has ordered the creation of a six-month stockpile of ingredients to make essential medicines, in another part of his push to reshore production.

News

Under pressure from Trump, Lilly hikes Mounjaro prices in UK

Lilly has said it will raise the UK list price of its diabetes and obesity therapy Mounjaro to bring it into parity with other European markets.

News

NHS cleared to use AZ's Fasenra for rare autoimmune disease

NICE backs NHS use of an AstraZeneca drug for one rare disease, but says it can't recommend a BioMarin therapy for another.

News

Artera gets FDA okay for prostate cancer AI

A newly approved AI from Artera can guide treatment and predict prognosis in people diagnosed with localised prostate cancer.

News

Texas suit claims Lilly bribed providers to prescribe drugs

Eli Lilly has been accused of giving illegal inducements to encourage medical providers in Texas to prescribe its medicines.

News

Insmed gets first FDA approval for bronchiectasis

Insmed has claimed the distinction of getting the first FDA approval for a treatment for chronic lung disease non-cystic fibrosis bronchiectasis.

Trump orders stockpiling of essential medicine ingredients

Under pressure from Trump, Lilly hikes Mounjaro prices in UK

NHS cleared to use AZ's Fasenra for rare autoimmune disease

Artera gets FDA okay for prostate cancer AI

Texas suit claims Lilly bribed providers to prescribe drugs

Insmed gets first FDA approval for bronchiectasis

Lilly partners with Hims & Hers on obesity drug sales

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks